NBIX- Neurocrine Biosciences, Inc.

Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.

Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Gorman Kevin Charles	517.8K	$80.89M	-
CEO	Gano Kyle	154.7K	$24.17M	-
Other	Benevich Eric	67.3K	$10.51M	-
Other	Lippoldt Darin	56.8K	$8.87M	-
CFO	Abernethy Matt	42.8K	$6.73M	-

Buys and sells only

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 10, 2025	Gorman Kevin Charles55	Director	Sale+OE	2,274	$118.37	$269,167.24	-0.4%	+1.4%	+15.9%
Feb 3, 2025	Delaet Ingrid66	Chief Regulatory Officer	Sale+OE	1,045	$150.81	$157,594.39	-23.3%	-26.9%	-7.4%
Jan 31, 2025	Abernethy Matt57	Chief Financial Officer	Sale+OE	1,283	$152.87	$196,135.80	-3.8%	-29.8%	-10.4%
Jan 31, 2025	Cooke Julie59	Chief Human Resources Officer	Sale+OE	1,740	$152.89	$266,024.95	-8.7%	-29.8%	-10.4%
Jan 31, 2025	Benevich Eric62	Chief Commercial Officer	Sale+OE	1,207	$152.94	$184,598.58	-2.8%	-29.8%	-10.4%
Jan 31, 2025	Boyer David W.51	Chief Corp. Affairs Officer	Sale+OE	1,104	$152.94	$168,849.40	-44.6%	-29.8%	-10.4%
Jan 31, 2025	Gano Kyle54	Chief Executive Officer	Sale+OE	1,541	$152.87	$235,577.45	-1.1%	-29.8%	-10.4%
Jan 31, 2025	Lippoldt Darin60	Chief Legal Officer	Sale+OE	1,250	$152.91	$191,133.00	-3.0%	-29.8%	-10.4%
Jan 31, 2025	Onyia Jude51	Chief Scientific Officer	Sale+OE	126	$152.97	$19,273.98	-0.8%	-29.8%	-10.4%
Jan 31, 2025	Roberts Eiry49	Chief Medical Officer	Sale+OE	1,457	$152.80	$222,636.16	-4.3%	-29.8%	-10.4%